About   Subscribe   Submit   My BJ   Librarians   Authors   Help
Editorial Board
Chair
PR Shepherd - Auckland

Vice Chair, The Americas
G Salvesen - La Jolla, CA

Vice Chair, Asia-Pacific
T Xu - Beijing

Vice Chair, Europe
DR Alessi - Dundee

Vice Chair, Reviews
A Toker - Boston, MA

Deputy Chairs - BJ Cell
D Hoekstra - Groningen
M Schwartz - Charlottesville, VA

Editors - BJ Cell
RA Anderson - Madison, WI
J Backer - Bronx, NY
J Blank - Cambridge, MA
LH Boise - Atlanta, GA
P Booth - Bristol
JF Caceres - Edinburgh
L Chernomordik - Bethesda, MD
AC Clark - Raleigh, NC
R Docampo - Athens, GA
C Duckett - Ann Arbor, MI
AF Dulhunty - Canberra
P Fay - Rochester, NY
R Golsteyn - Lethbridge, AB
DA Jans - Monash
D Laird - London, Ont.
K Lingelbach - Marburg
L Machesky - Glasgow
E Manser - Singapore
J Miernyk - Columbia, MO
H Naim - Hannover
PF Pilch - Boston, MA
A Postle - Southampton
M Seabra - London
FJ Sharom - Guelph, Ont.
E Smythe - Sheffield
S Stack - Columbia, MO
H Stenmark - Oslo
M Torti - Pavia
HD Ulrich - South Mimms
H Yagisawa - Hyogo-Ken
C Zurzolo - Paris
Biochem. J. (2002) 367 (907–911) (Printed in Great Britain)
Small ubiquitin-related modifier-1 (SUMO-1) modification of the glucocorticoid receptor
Sha TIAN* , Hetti POUKKA* , Jorma J. PALVIMO*† and Olli A. JÄNNE*‡1
*Biomedicum Helsinki, Institute of Biomedicine, University of Helsinki, P.O. Box 63 (Haartmaninkatu 8), FIN-00014 Helsinki, Finland, †Institute of Biotechnology, P.O. Box 56, University of Helsinki, FIN-00014 Helsinki, Finland, and ‡Department of Clinical Chemistry, P.O. Box 63, University of Helsinki and Helsinki University Central Hospital, FIN-00014 Helsinki, Finland

Small ubiquitin-related modifier-1 (SUMO-1) is covalently attached to many cellular targets to regulate protein–protein and protein–DNA interactions, as well as localization and stability of the target protein. The SUMO-1-conjugating E2 enzyme Ubc9 is known to interact with the glucocorticoid receptor (GR), a ligand-dependent transcription factor. In the present study, we show that GR is post-translationally modified by SUMO-1 (sumoylated) in a ligand-enhanced fashion. We identify experimentally three consensus SUMO attachment sites, two in the N-terminal transactivation region and one in the ligand-binding domain of GR. The two N-terminal sites are the major acceptor sites for SUMO-1 attachment. Mutation of these sites enhances transcriptional activity of GR on minimal promoters, but has no clear effect on the more complex mouse mammary tumour virus promoter. Thus SUMO-1 modification of GR influences receptor function in a promoter context-dependent fashion.


Key words: nuclear receptor, sumoylation, transactivation.

Abbreviations used: AR, androgen receptor; FBS, foetal bovine serum; GR, glucocorticoid receptor; K277R, Lys277Arg; LUC, luciferase; PR, progesterone receptor; SUMO-1, small ubiquitin-related modifier-1.

1To whom correspondence should be addressed at Biomedicum Helsinki (e-mail olli.janne@helsinki.fi).


Received 10 July 2002; accepted 29 July 2002

Published as BJ Immediate Publication 29 July 2002, DOI 10.1042/BJ20021085


The Biochemical Society, London © 2002

Chinese users - get faster access here
 
 
 
Make it personal - with My BJ!
Bookmark with:
Bookmark with Del.icio.us Bookmark with Connotea
 
 
Banner image courtesy Dr Gordon Beakes, Newcastle University